Literature DB >> 1398510

Angiocentric T-cell lymphoma of the nose, paranasal sinuses and hard palate.

A Aviles1, L Rodriguez, R Guzman, A Talavera, E L Garcia, J C Diaz-Maqueo.   

Abstract

Sixty-five cases of malignant lymphoma of the nose, paranasal sinuses and hard palate were retrospectively analysed to identify the presence or absence of angiocentric lesions. We observed that the 23 patients with angiocentric lesions had a worse prognosis with a shorter duration of response and also a shorter duration of survival, compared with 42 cases of malignant lymphoma of the same anatomical region but without angiocentric lesions. Patients with angiocentric lymphoma were associated with other bad prognostic factors such as elevated levels of lactic dehydrogenase and beta 2 microglobulin, local bone destruction and lymphopenia. Immunophenotyping studies showed that most patients with angiocentric lesions had T cell lymphomas (18 of 23, 78 per cent). We believe that patients with angiocentric T cell lymphomas of the nose, paranasal sinuses and hard palate represent a distinctive clinico-pathological entity with different clinical presentation and outcome. Patients with angiocentric T cell lymphomas had frequent relapse at extranodal sites and combined therapy should be considered as the initial therapeutic approach.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1398510     DOI: 10.1002/hon.2900100303

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN: 0278-0232            Impact factor:   5.271


  6 in total

1.  Treatment outcome of radiotherapy alone versus radiochemotherapy in early stage nasal natural killer/T-cell lymphoma.

Authors:  Hui-Hui Ma; Li-Ting Qian; Hai-Feng Pan; Lin Yang; Hong-Yan Zhang; Zhi-Hua Wang; Jun Ma; Yu-Fei Zhao; Jin Gao; Ai-Dong Wu
Journal:  Med Oncol       Date:  2009-08-15       Impact factor: 3.064

2.  Combined therapy in untreated patients improves outcome in nasal NK/T lymphoma: results of a clinical trial.

Authors:  Agustin Avilés; Natividad Neri; Raúl Fernández; Judith Huerta-Guzmán; Maria-Jesus Nambo
Journal:  Med Oncol       Date:  2013-06-25       Impact factor: 3.064

3.  Nasal NK/T-cell lymphoma with disseminated disease treated with aggressive combined therapy.

Authors:  Agustin Avilés; Natividad Neri; Raúl Fernández; Angel Calva; Judith Huerta-Guzmán; M Jesús Nambo
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

4.  Adoptive transfer of Epstein-Barr virus-specific cytotoxic T-lymphocytes for the treatment of angiocentric lymphomas.

Authors:  Hyun-Il Cho; Young Seon Hong; Myung Ah Lee; Eun-Kyung Kim; Sung-Hee Yoon; Chun-Choo Kim; Tai-Gyu Kim
Journal:  Int J Hematol       Date:  2006-01       Impact factor: 2.490

Review 5.  Extranodal NK/T-cell lymphoma: toward the identification of clinical molecular targets.

Authors:  Christian Schmitt; Nouhoum Sako; Martine Bagot; Yenlin Huang; Philippe Gaulard; Armand Bensussan
Journal:  J Biomed Biotechnol       Date:  2011-04-20

Review 6.  Nasal NK/T-Cell Lymphoma. A Comparative Analysis of a Mexican Population with the Other Populations of Latin-America.

Authors:  Agustin Avilés
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-09-01       Impact factor: 2.576

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.